Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y9HH
|
||||
Former ID |
DNC001325
|
||||
Drug Name |
SIB-1508Y
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H14N2
|
||||
Canonical SMILES |
CN1CCCC1C2=CN=CC(=C2)C#C
|
||||
InChI |
1S/C12H14N2/c1-3-10-7-11(9-13-8-10)12-5-4-6-14(12)2/h1,7-9,12H,4-6H2,2H3
|
||||
InChIKey |
NUPUDYKEEJNZRG-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 192231-16-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | ||
References | |||||
Ref 525768 | Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharm Acta Helv. 2000 Mar;74(2-3):125-30. | ||||
Ref 529637 | Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist. Brain Res. 2008 Oct 9;1234:16-24. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.